meclofenamic acid has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kather, H; Simon, B | 1 |
| Fujimura, S; Iwabuchi, S; Koike, K; Ono, S; Tanita, T | 1 |
2 other study(ies) available for meclofenamic acid and vasoactive intestinal peptide
| Article | Year |
|---|---|
Human colonic adenylate cyclase. Stimulation of enzyme activity by vasoactive intestinal peptide and various prostaglandins via distinct receptor sites.
Topics: Adenylyl Cyclases; Colon; Epoprostenol; Female; Gastrointestinal Hormones; Humans; Intestinal Mucosa; Male; Meclofenamic Acid; ortho-Aminobenzoates; Prostaglandins; Prostaglandins D; Prostaglandins E; Receptors, Cell Surface; Receptors, Prostaglandin; Vasoactive Intestinal Peptide | 1980 |
Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung.
Topics: Angiotensin II; Animals; Enzyme Inhibitors; In Vitro Techniques; Lung; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Pulmonary Circulation; Rats; Rats, Inbred BUF; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1997 |